Nasus Pharma Ltd Diluted Shares Outstanding (Weighted Average)
Nasus Pharma Ltd (NSRX) reported Diluted Shares Outstanding (Weighted Average) of 8.01 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-03-25
| Period end | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|
| 2025-12-31 | 8.01M shares 20-F · filed 2026-03-25 | |
| 2025-06-30 | 7.36M shares 6-K · filed 2025-12-29 | |
| 2024-12-31 | 7.03M shares 20-F · filed 2026-03-25 | |
| 2024-06-30 | 6.89M shares 6-K · filed 2025-12-29 | |
| 2023-12-31 | 7.06M shares 20-F · filed 2026-03-25 |